Related Practice Life Sciences & Pharma Orphan drugs are expected to play an increasingly prominent role in the biopharmaceutical industry. The worldwide orphan market grew at ~8 percent per year over the past five years (from $79B to $114B). 08052019090827
Video / Webinar Life Sciences & Pharma Meet L.E.K.'s Pharmaceutical Services Practice September 20, 2023
Special Report Life Sciences & Pharma Medical Communications Trends: Outsourcing Implications and Transformation June 22, 2023
Executive Insights Biotech and Pharmaceuticals The Power of Prediction: How Generative AI Can Drive Biopharma Strategy May 30, 2023
Published Articles Mental and Behavioral Health Trip or No Trip? The Diverging Development of Psychedelic Drugs for Mental Health … December 15, 2022